BofA cuts ratings on four biopharma stocks over valuation and catalyst concerns
Go back to BofA cuts ratings on four biopharma stocks over valuation and catalyst concerns| ALKERMES (NASDAQ: ALKS) | Delayed: 52.58 -0.27 (0.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $52.85 | 52 Week High | $80.71 | |||
| Open | $52.55 | 52 Week Low | $27.14 | |||
| Day High | $53.27 | P/E | 404.46 | |||
| Day Low | $52.35 | EPS | $0.13 | |||
| Volume | 1,837,064 | |||||
| AMER PHYSICIANS (NASDAQ: AMPH) | Delayed: 19.30 -0.29 (1.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $19.59 | 52 Week High | $21.53 | |||
| Open | $19.71 | 52 Week Low | $10.50 | |||
| Day High | $19.95 | P/E | 5.90 | |||
| Day Low | $19.20 | EPS | $3.27 | |||
| Volume | 409,242 | |||||
| (NYSE: BHVN) | Delayed: 14.75 -0.76 (4.9%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.51 | 52 Week High | $ | |||
| Open | $15.26 | 52 Week Low | $ | |||
| Day High | $15.50 | P/E | N/A | |||
| Day Low | $14.56 | EPS | $ | |||
| Volume | 2,169,531 | |||||
